Oncogenes as inducers of tumor angiogenesis (original) (raw)
References
Barbacid M: ras genes. Ann Rev Biochem 56: 779–827, 1987 Google Scholar
Pronk GJ, Bos JL: The role of p21_ras_ in receptor tyrosine signalling. Biochim Biophys Acta 1198: 131–147, 1994 Google Scholar
Khosravi-Far R, Der CJ: The Ras signal transduction pathway. Cancer Metastasis Rev in press: 1995
Buick RN, Filmus J, Quaroni A: Activated H-ras transforms rat intestinal epithelial cells with expression of α-TGF. Exp Cell Res 170: 300–309, 1987 Google Scholar
Filmus J, Robles AL, Shi W, Wong MJ, Colombo LL, Conti CJ: Induction of cyclin D1 overexpression by activated_ras_. Oncogene 9: 3726–3633, 1994 Google Scholar
Bischop M: Molecular themes in oncogenesis. Cell 64: 235–248, 1991 Google Scholar
Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82: 4–6, 1990 Google Scholar
Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1: 149–153, 1995 Google Scholar
Rak JN, St. Croix B, Kerbel RS: Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs 6: 3–18, 1995 Google Scholar
Thompson TC, Southgate J, Kitchener G, Land H: Multistage carcinogenesis induced by_ras_ and_myc_ oncogenes in a reconstituted organ. Cell 56: 917–930, 1989 Google Scholar
Sugihara T, Kaul SC, Mitsui Y, Wadhwa R: Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts. Biochim Biophys Acta 1224: 365–370, 1994 Google Scholar
Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during transition from hyperplasia to neoplasia. Nature 339: 58–61, 1989 Google Scholar
Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095–1104, 1991 Google Scholar
Rak J, Mitsuhashi Y, Bayko L, Filmus J, Sasazuki T, Kerbel RS: Mutant_ras_ oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575–4580, 1995 Google Scholar
Grugel S, Finkenzeller G, Weindel K, Barleon B, Marmé D: Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 270: 25915–25919, 1995 Google Scholar
Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798–1801, 1992 Google Scholar
Hu DE, Hory Y, Fan TP: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17: 135–143, 1993 Google Scholar
Petzelbauer P, Watson CA, Pfau SE, Pober JS: IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8_in vitro_. Cytokine 7: 267–272, 1995 Google Scholar
Baird A, Durkin T: Inhibition of endothelial cell proliferation by type-beta transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 138: 476–482, 1986 Google Scholar
Frater-Schroder M, Muller G, Birchmeier W, Bohlen P: Transforming growth factor beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137: 295–302, 1986 Google Scholar
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis_in vivo_ and stimulation of collagen formation_in vitro_. Proc Natl Acad Sci (USA) 83: 4167–4171, 1986 Google Scholar
Risau W: Differentiation of endothelium. FASEB J 9: 926, 1995 Google Scholar
Senger DR, Perruzzi CA, Feder J, Dvorak HG: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629–5632, 1986 Google Scholar
Senger DR, Connolly D, Perruzzi CA, Alsup D, Nelson R, Leimgruber R, Feder J, Dvorak HF: Purification of a vascular permeability factor (VPF) from tumor cell conditioned medium. Fed Proc 46: 2102, 1987 Google Scholar
Dvorak HF, Brown LF, Detmar M, Dvorak AM: Review: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029–1039, 1995 Google Scholar
Kolch W, Martiny-Baron G, Kieser A, Marmé D: Regulation of the expression of VEGF/VPF and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 36: 139–155, 1995 Google Scholar
Klagsbrun M, Soker S: VEGF/VPF: the angiogenesis factor found? Curr Biol 3: 699–702, 1993 Google Scholar
Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36: 127–137, 1995 Google Scholar
Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895–898, 1995 Google Scholar
Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factorinduced angiogenesis suppresses tumour growth_in vivo_. Nature 362: 841–844, 1993 Google Scholar
Warren RS, Yuan H, Mati MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789–1797, 1995 Google Scholar
Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited_in vivo_ by a dominant-negative Flk-1 mutant. Nature 367: 576–579, 1994 Google Scholar
Toi M, Inada K, Suzuki H, Tominage T: Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193–204, 1995 Google Scholar
Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845, 1992 Google Scholar
Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577–581, 1995 Google Scholar
Stein I, Neeman M, Shweiki D, Itin A, Keshet E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemiainduced genes. Mol Cell Biol 15: 5363–5368, 1995 Google Scholar
Kieser A, Weich HA, Brandner G, Marmé D, Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 363–369, 1994 Google Scholar
Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. J Biol Chem 266: 11947–11954, 1991 Google Scholar
Finkenzeller G, Technau A, Marmé D: Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun 208: 432–439, 1995 Google Scholar
Jamal H, Cano-gauci DF, Buick RN, Filmus J: Activated_ras_ and_src_ induce CD44 overexpression in rat intestinal epithelial cells. Oncogene 9: 417–423, 1994 Google Scholar
Shirasawa S, Furuse M, Yokoyama N, Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85–88, 1993 Google Scholar
Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH: Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202: 1–8, 1992 Google Scholar
Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL: Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci (USA) 87: 6698–6702, 1990 Google Scholar
Kibbey MC, Grant DS, Kleinman HK: Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an_in vivo_ matrigel model. J Natl Canc Inst 84: 1633–1638, 1992 Google Scholar
Kobayashi H, Man S, MacDougall JR, Graham CH, Lu C, Kerbel RS: Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine resistant phenotype. Am J Pathol 144: 776–786, 1994 Google Scholar
Bonfil RD, Vinyals A, Bustuoabad OD, Llorens A, Benavides FJ, Gonzales-Garrigues M, Fabra A: Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity. Int J Cancer 58: 233–239, 1994 Google Scholar
Klein G: Multistep emancipation of tumors from growth control: can it be cured in a single step? BioEssays 12: 347–351, 1990 Google Scholar
Dameron KM, Volpert OV, Tainsky MA, Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582–1584, 1994 Google Scholar
Van Meir EG, Polverini PJ, Chazin VR, Huang SH-J, Tribolet N, Cavanee WK: Release of an inhibitor of angiogenesis upon induction of wild type_p_53 expression in glioblastoma cells. Nature Genetics 8: 171–182, 1994 Google Scholar
Huang H-JS, Yee J-K, Shew J-Y, Chen P-L, Bookstein R, Friedmann T, Lee EY-HP, Lee W-H: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563–1566, 1988 Google Scholar
Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated_RB_ gene. Science 247: 712, 1995 Google Scholar
Iliopoulos O, Kibel A, Gray S, Kaelin Jr WG: Tumour suppression by the human von Hippel-Lindau gene product. Nature Medicine 1: 822, 1995 Google Scholar
Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor andits receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358–1364, 1995 Google Scholar
Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine 1: 1024–1028, 1995 Google Scholar
Strawhecker JM, Pelling JC: Inhibition of mouse skin tumorigenesis by dexamethasone occurs through a Ha-_ras_-independent mechanism. Carcinogenesis 13: 2075–2080, 1992 Google Scholar
Lee K, Iwamura M, Crockett ATK: Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice. Cancer Chemoth Pharm 26: 461–463, 1990 Google Scholar
Lee K, Erturk E, Mayer R, Cockett ATK: Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer Res 47: 5021–5024, 1987 Google Scholar
Kerppola TK, Luk D, Curran T: Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol 13: 3782–3791, 1993 Google Scholar
Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM: c-fos is required for malignant progression for skin tumors. Cell 82: 721–732, 1995 Google Scholar
Anzano M, Roberts A, Delarco J, Wakefield L, Assoian R, Roche N, Smith J, Lazarus J, Sporn M: Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol Cell Biol 5: 242–247, 1985 Google Scholar
Pertovaara L, Kaipanen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269: 6271–6274, 1994 Google Scholar
Detmar M, Brown LF, Claffey KP, Kiang-Teck Y, Kocher O, Jackman RW, Berse B, Dvorak HFL Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180: 1141–1146, 1994 Google Scholar
Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis_in vitro_. Biochem Biophys Res Commun 189: 824–831, 1992 Google Scholar
Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508, 1993 Google Scholar
Toi M, Inada K, Hoshima S, Suzuki H, Kondo S, Tominaga T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1: 961–964, 1995 Google Scholar
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990 Google Scholar
Galand P, Jacobovitz D, Alexandre K: Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. Int J Cancer 41: 155–161, 1995 Google Scholar
Hasegawa H, Ueda M, Watanabe M, Teramoto T, Mukai M, Kitajima M: K-ras gene mutations in early colorectal cancer... flat elevated vs polyp-forming cancer... Oncogene 10: 1413–1416, 1995 Google Scholar
Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H: Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 54: 2841–2844, 1994 Google Scholar
Rak J, Mituhashi Y, Erdos V, Huang S-N, Filmus J, Kerbel RS: Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogenes. J Cell Biol in press: 1995
Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3: 211–220, 1992 Google Scholar
Ohta Y, Tone T, Shitara T, Funato T, Jiao L, Kashfian BI, Yoshida E, Horng M, Tsai P, Lauterbach K, Kashani-Sabet M, Florenes VA, Fodstad O: H-ras ribozyme-mediated alteration of the human melanoma phenotype. Gene Therapy Neopl Dis 716: 242, 1994 Google Scholar
Kashani-Sabet M, Funato T, Tone T, Jiao L, Wang W, Yoshida E, Kashfinn BI, Shitara T, Wu AM, Moreno JG, Traweek ST, Ahlering TE, Scanlon KJ: Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res Dev 2: 3–15, 1992 Google Scholar
Ferrari G, Greene LA: Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. EMBO J 13: 5922–5928, 1994 Google Scholar
Sakai N, Ogiso Y, Fujita H, Watari H, Koike T, Kuzumaki N: Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp Cell Res 215: 131–136, 1994 Google Scholar
James GL, Goldstein JL, Brown MS: Polylysine and DVIM sequences of K-rasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic_in vitro_. J Biol Chem 270: 6221–6226, 1995 Google Scholar
Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB: Selective inhibition of_ras_-dependent transformation by a farnesyltransferase inhibitor. Science 260: 1934–1942, 1993 Google Scholar
Gibbs JB, Oliff A, Kohl NE: Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic. Cell 77: 175–178, 1994 Google Scholar
Lowry DR, Willumsen BM: Rational cancer therapy. Nature Medicine 1: 747–748, 1995 Google Scholar
Kiaris H, Spandidos DA: Mutations of_ras_ genes in human tumours. Int J Oncol 7: 413–421, 1995 Google Scholar
Kohl NE, Wilson FR, Mossier SD, Giuliani E, deSolms SJ, Conner MW, Anthony NJ, Holtz WJ, Gomez RP, Lee T-J, Smith RL, Graham SL, Hartman GD, Gibbs JB, Oliff A: Protein farnesyltransferase inhibitors block the growth of_ras_-independent tumors in nude mice. Proc Natl Acad Sci (USA) 91: 9141–9145, 1994 Google Scholar
Kohl NE, Omer CA, Conner MW, Anthony NJ, Davide JP, deSolms SJ, Giuliani EA, Gomez RP, Graham SL, Hamilton K, Handt LK, Hartman GD, Koblan KS, Kral AM, Miller PJ, Mosser SD, O'Neill TJ, Rands E, Schaber MD, Gibbs JB, Oliff A: Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in_ras_ transgenic mice. Nature Medicine 1: 792–797, 1995 Google Scholar
Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ: Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci (USA) 92: 4562–4566, 1995 Google Scholar
Burrows FJ, Thorpe PE: Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci (USA) 90: 8996–9000, 1993 Google Scholar
Bouck N: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2: 179–185, 1990 Google Scholar